NDC product
LUMIFY Redness Reliever Eye Drops
NDC 24208-537 · Bausch & Lomb Incorporated
Key facts
| Product NDC | 24208-537 |
|---|---|
| Proprietary name | LUMIFY Redness Reliever Eye Drops |
| Nonproprietary name | BRIMONIDINE TARTRATE |
| Substances | BRIMONIDINE TARTRATE |
| Dosage form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | Bausch & Lomb Incorporated |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA208144 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| Marketing start | Dec 22, 2017 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: